Anthelmintic use of nodulisporic acid and analogs thereof
US5595991A · kind A · utility
6Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 1995 |
| Grant date | Jan 21, 1997 |
| Priority date | — |
| Expiry date | Mar 20, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for the treatment of helminthiasis which comprises administering to an infected host an effective amount of nodulisporic acid or a analog thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.